D-922-2013 Class I Terminated

Recalled by Hospira Inc. — Lake Forest, IL

FDA drug recall D-922-2013 was initiated by Hospira Inc. on Aug 31, 2012 and is designated Class I. Reason for recall: Presence of Particulate Matter; product may contain fibrous material The recall status is terminated (terminated May 28, 2015). Affected quantity: 264,432 bags.

Recall Details

Product Type
Drugs
Report Date
Sep 4, 2013
Initiation Date
Aug 31, 2012
Termination Date
May 28, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
264,432 bags

Product Description

0.9% Sodium Chloride Injection, USP, 100 mL flexible container, Rx only, Hospira, Inc. Lake Forest, IL 60045 --- NDC 0409-7984-23

Reason for Recall

Presence of Particulate Matter; product may contain fibrous material

Distribution Pattern

Nationwide

Code Information

Lot Number 05-201-JT, Expiration Date 1MAY2013

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-922-2013
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.